CION Cancer Clinics
How long does follow-up continue after liver cancer treatment? | CION Cancer Clinics
For most people treated for primary liver cancer, follow-up continues for life, especially with cirrhosis or hepatitis B. Checks are closest together in the first two years, then spread out into a steady routine. This page explains why the liver is watched for so long, what sets the gaps between scans, and what changes over the years. At CION Cancer Clinics, our team supports patients and families through symptoms, follow-up and life during and after treatment.
On this page
- How many years does liver cancer follow-up last?
- What decides how long and how often you are checked?
- What does follow-up look like from year to year?
- Which words will you see on your follow-up reports?
- What do families get wrong about stopping follow-up?
- What can this page not tell you about your own follow-up?
- Common questions about how long follow-up lasts
The short answer
How many years does liver cancer follow-up last?
For most people treated for primary liver cancer, follow-up does not really end. The visits are closest together in the first two years, then spread out, and for most people they settle into regular liver checks that continue for life. That can sound grim. It is actually the plan that gives you the best chance of catching anything early, while it is still small and treatable.
Why liver cancer is different
After most cancers, the organ that grew the tumour has been removed or treated. With liver cancer, the rest of the liver stays. If that liver also has cirrhosis, hepatitis B or C, or long-standing fatty liver, the same conditions that caused the first tumour can cause a new one years later. So follow-up has two jobs: watching for the old cancer coming back, and watching the remaining liver for a fresh one.
Which liver cancer this page is about
This page is about cancer that started in the liver, called hepatocellular carcinoma (HCC). If your cancer spread to the liver from the bowel or elsewhere, follow-up is planned around where it started. Read what secondary liver cancer means first.
Follow-up that becomes lifelong is a sign of a watchful plan, not a sign that something is wrong.What sets the length
What decides how long and how often you are checked?
Your team weighs a few things. None of them is a judgement about you; each one changes how much the liver needs watching.
The state of the remaining liver
A liver with cirrhosis keeps a raised risk of a new tumour for life. A liver that was healthy apart from the tumour carries less ongoing risk, and the checks may be spaced out sooner.
The treatment you had
Resection, ablation, TACE and transplant each leave a different picture on the scan. Your team times the early scans around the treatment and what it is known to leave behind.
For example
- After ablation, the first scan checks the treated area is fully dead
- After a transplant, the transplant centre leads the plan
The cause of the liver disease
Hepatitis B stays controlled, not cleared, so the risk it brings continues. Hepatitis C treated successfully with tablets lowers risk but does not remove it if cirrhosis has already formed.
What the first scans show
Several clear scans in a row usually allow the gap to widen. A doubtful spot or a rising AFP (a blood marker some liver cancers make) brings the next check forward.
Not sure whether this applies to you?
Ask an oncologistThe usual shape
What does follow-up look like from year to year?
-
The first check after treatment
A scan, usually a contrast CT or MRI, a few weeks after treatment shows whether the tumour was fully treated. This becomes the new baseline every later scan is compared with.
-
The first two years
This is when the old cancer is most likely to come back. Most guidelines advise a scan and an AFP every three to six months, with a clinic visit and liver blood tests alongside.
-
The next few years
If scans stay clear, the gap usually widens to around every six months. Your oncologist may move from CT or MRI to ultrasound if your liver can be seen well on it.
-
The long term
For anyone with cirrhosis or ongoing hepatitis B, regular liver surveillance continues, much like the ultrasound plus AFP checks people with cirrhosis are offered before any cancer. It becomes a routine rather than an event.
-
Alongside, the liver itself
Hepatology care, antiviral tablets where needed, and checks for varices and fluid carry on in parallel. These protect the liver that any future treatment would depend on.
On your follow-up papers
Which words will you see on your follow-up reports?
- Surveillance
- Regular checks in someone who looks well, to find a problem early. After treatment it means watching for a return or a new tumour.
- Recurrence
- The original cancer coming back, in the liver or elsewhere.
- New primary
- A separate tumour arising in another part of the same liver. It is treated as a new cancer, often with the same options as the first.
- Complete response
- The scan shows no living tumour in the area that was treated.
- AFP
- Alpha-fetoprotein, a blood marker some liver cancers make. Its trend over time matters more than one value.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
A new tumour found years later in the same liver is often a separate cancer, not the first one returning. Found small on a routine scan, it may still be treatable with the same options you had before, which is the whole point of staying in follow-up.
Commonly believed
What do families get wrong about stopping follow-up?
The five-year marker comes from other cancers. In a liver with cirrhosis, the risk of a new tumour does not reach zero at any fixed point, so the checks continue even when every scan has been clear.
Early liver cancer rarely causes symptoms. Feeling well is the expected state in follow-up, and it tells you nothing about what a scan would show. Missed scans are a common reason a treatable tumour is found late.
It means the liver that remains is still at risk, and nobody can predict which person will have a new tumour. Watching everyone closely is how the people who do get one are found early.
Transplant follow-up also watches for the cancer returning elsewhere in the body. The transplant centre sets that plan, and it runs alongside anti-rejection care.
Being straight with you
What can this page not tell you about your own follow-up?
It cannot give you your own schedule. Guidelines describe a usual shape, and your oncologist adjusts it to your liver, your treatment and your scans. Ask for your plan in writing: which test, how often, and who reads the result. The follow-up schedule page explains each visit in more detail.
It cannot tell you your risk of it coming back
That depends on the tumour, the liver and the treatment, and even then it is an estimate for a group, not a forecast for one person. Your team can talk it through with you honestly.
Who this does not apply to
If your cancer spread to the liver from the bowel, breast or elsewhere, follow-up belongs to the cancer that started it. If you are on treatment for advanced disease rather than in follow-up, your scans are checking the response to treatment, which is a different rhythm. People after a transplant follow the transplant centre's plan first.
At CION, follow-up and surveillance planning happen at the clinic; scans are arranged through accredited diagnostic partners.Questions we are asked
Common questions about how long follow-up lasts
Will I ever be discharged from follow-up?
If you have cirrhosis or hepatitis B, most likely not fully, because the remaining liver keeps a raised risk. The visits do become less frequent and simpler. If your liver was healthy apart from the tumour, your oncologist may space checks out further after several clear years. Ask them directly.
Why are the early scans so close together?
The first two years are when the original cancer is most likely to come back. Close scans in that window mean a return is found while it is small and there are still several ways to treat it. After that, the gaps can usually widen.
Can ultrasound replace CT or MRI later on?
Sometimes. Once scans have been clear for a while, an ultrasound with AFP may be enough if your liver shows up well on it. In a scarred or fatty liver, ultrasound can miss small spots, so your oncologist may keep CT or MRI. That choice is theirs to make with you.
Does a normal AFP mean I can skip the scan?
No. Some liver cancers never raise AFP, so a normal value does not rule anything out. The blood test and the scan do different jobs and are used together. A rising AFP with a clear scan is a reason for a closer look, not for alarm.
What if we miss a scan because of travel or money?
Rebook as soon as you can rather than waiting for the next due date. One late scan is rarely a disaster; a habit of missing them is the real risk. Tell your team what got in the way, as there may be a simpler or closer option.
Do I still need my hepatitis B tablets during follow-up?
Usually yes. Hepatitis B is controlled, not cleared, and stopping antiviral tablets without advice can cause a dangerous flare. Decisions about them belong to your hepatologist or physician. Read about continuing antiviral treatment.
Is follow-up the same after a transplant?
It is different. The transplant centre leads it, and it covers the new liver, anti-rejection medicines and checks for the cancer returning elsewhere in the body. Your oncologist can work alongside them, but their plan comes first.
Who can help me plan long-term follow-up?
Your treating oncologist is the right person to set it. If you are unsure your plan is right, or you were treated elsewhere and want it reviewed, call the CION helpline. A team member will arrange a consultation and help organise the scans.
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Living as a Liver Cancer Survivor
- American Cancer Society — After Liver Cancer Treatment
- EASL — EASL Clinical Practice Guidelines: management of hepatocellular carcinoma
- American Cancer Society — Cancer Recurrence
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Not sure your follow-up plan is the right one?
Bring your treatment summary and your latest scans, and an oncologist will go through your follow-up plan with you. We can also help arrange the scans and blood tests it needs. One helpline serves every CION centre.